Discontinuation report VIBERZI
Report ID | 157159 |
Drug Identification Number | 02460904 |
Brand name | VIBERZI |
Common or Proper name | Viberzi (Eluxadoline Tablets) |
Company Name | ALLERGAN INC |
Market Status | MARKETED |
Active Ingredient(s) | ELUXADOLINE |
Strength(s) | 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 60s |
ATC code | A07DA |
ATC description | |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | |
Remaining supply date | 2022-09-30 |
Discontinuation status | Reversed |
Discontinuation decision reversal | Yes |
Information on remaining supply | |
Company comments | Reversal of discontinuation decision |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2022-06-22 | French | Compare |
v4 | 2022-06-22 | English | Compare |
v3 | 2022-03-23 | French | Compare |
v2 | 2022-03-23 | French | Compare |
v1 | 2022-03-23 | English | Compare |
Showing 1 to 5 of 5